CVE-2026-24217

high

Published 2026-05-20 · Modified 2026-05-21

CVSS v3

8.8

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

CVSS v2

—

VIR risk

8.8

Description

NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

Predictions

Exploit likelihood

92%

Patch ETA

—

Heuristic predictions, AS-IS, for prioritization only.

Mitigations

vendor Authored 2026-05-27

Vendor advisory: psirt@nvidia.com — https://nvidia.custhelp.com/app/answers/detail/a_id/5831

OS impact

OS	Version	Status	Fixed in
linux-kernel	-	not-affected

Application impact

Vendor	Product	Versions	Fixed
nvidia	bionemo_framework	`{"endExcluding":"2026-04-03"}`	`2026-04-03`

References

https://nvd.nist.gov/vuln/detail/CVE-2026-24217
https://nvidia.custhelp.com/app/answers/detail/a_id/5831
https://www.cve.org/CVERecord?id=CVE-2026-24217

CWEs

CWE-29

Verify integrity in audit chain (admin only). AS-IS.